Investors: Don’t Miss Out on This $1.2 Trillion Opportunity

Investing in our aging population could make a lot of investors rich. Stocks such as Extendicare Inc. (TSX:EXE) and Jean Coutu Group PGC Inc. (TSX:PJC.A) look particularly attractive.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Here at Motley Fool Canada, we’re big fans of searching for the best opportunities out there.

To borrow a baseball analogy, other investors might be content searching for low-risk singles or doubles. We’re not. We search for the kinds of stocks that could potentially be home runs. Those are the kinds of opportunities that can really make a difference in a portfolio.

The tricky part isn’t finding these kinds of opportunities. There are plenty of examples out there. The issue is finding a massive potential market that is being discounted and then getting into it before other investors figure out what’s going on.

In other words, we’re looking for opportunities that are in the second inning — not ones in the sixth inning.

I believe such a scenario is unfolding today, and investors have largely been ignoring it. Here’s how you can profit before the rest of the market wakes up and seizes the opportunity.

A $1.2 trillion market

They say there are two certainties in life: death and taxes. I’d like to add a third.

Getting old.

Canada is filled with Baby Boomers who are going to put a great strain on our medical system someday. More than nine million Baby Boomers are retiring en masse, which is good news for struggling millennials looking to make more money. Don’t worry, kids; opportunities are coming.

According to the latest estimates, taking care of aging Baby Boomers will be a massive opportunity — a $1.2 trillion opportunity. And that’s just in Canada alone. Both the United States and Europe will spend even more taking care of their aging populations.

Think about all the expenses associated with getting older. Someone has to pay for all their medical care and prescriptions. They have to go to the hospital or clinic. And then, when their age really catches up to them, they’re forced to enter an assisted-living home, usually with great reluctance.

Here are a couple ways you can profit from this upcoming megatrend.

Extendicare 

I started buying Extendicare Inc. (TSX:EXE) shares in 2015, back when they traded under $7 each. I was impressed with the company’s decision to exit the much more competitive U.S. market, which would free up cash to be invested in Canada.

It worked. Extendicare used the cash from the sale of U.S. assisted-living facilities to acquire additional facilities here in Canada as well as doubled the size of its home-healthcare business, an underrated part of the medical industry. It’s a lot cheaper for governments to send a nurse over to help care for a senior than shoving them into a home.

Although Extendicare shares are currently $10.56 each, I still rank the stock a buy today. Earnings were quite strong in the last quarter and should continue to be strong in 2017. Shares pay an attractive 4.5% dividend as well.

Jean Coutu 

Jean Coutu Group PJC Inc. (TSX:PJC.A) is Quebec’s largest chain of pharmacies; it also has locations in Ontario and New Brunswick.

Most businesses would love the same kind of customer loyalty most pharmacists get. Since a pharmacist is an important part of someone’s whole healthcare experience — especially as we get older — customers tend to stick around for a long time. And most get prescriptions refilled monthly, ensuring a dependable revenue stream. It’s a nice business.

Jean Coutu trades at 18.4 times trailing earnings and pays a 2.4% dividend.

The bottom line

Both Extendicare and Jean Coutu are great ways to play the upcoming aging population boom. It won’t happen overnight, but I think patient investors who get in today will be greatly rewarded in a few years as the market begins to wake up to the massive opportunity in front of them. The key is to get in before it becomes the next sure thing.

Should you invest $1,000 in Extendicare right now?

Before you buy stock in Extendicare, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Extendicare wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,345.77!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*.

See the Top Stocks * Returns as of 4/21/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Nelson Smith owns shares of EXTENDICARE INC. Extendicare is a recommendation of Stock Advisor Canada.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Dividend Stocks

sale discount best price
Dividend Stocks

This Monthly Dividend Stock at $53 Is Too Cheap to Ignore

There are plenty of great dividend stocks on the market to consider buying, but this monthly gem is just too…

Read more »

ETF stands for Exchange Traded Fund
Dividend Stocks

The Best Canadian ETFs $1,000 Can Buy on the TSX Today

If you're looking for ETFs that can turn $1,000 into strong cash flow, then these are the ones I'd go…

Read more »

Silver coins fall into a piggy bank.
Dividend Stocks

Where I’d Invest my TFSA Savings in the TSX Today

If you want the stability of defence with the growth from tech, this is the ideal stock.

Read more »

Blocks conceptualizing Canada's Tax Free Savings Account
Dividend Stocks

How I’d Invest $7,000 in My TFSA to Earn $50 in Monthly Income

High-yield stocks like Freehold Royalties, which is yielding more than 9%, are prime candidates for your TFSA.

Read more »

dividend growth for passive income
Dividend Stocks

4 Canadian Dividend Stocks to Buy and Hold for the Next 20 Years

These dividend stocks can certainly stand the test of time, and have already done so for many investors.

Read more »

Stethoscope with dollar shaped cord
Dividend Stocks

I’d Put My Entire $7,000 TFSA Into This Single Dividend Stock

TFSA investors can consider putting their $7,000 limit into a top-performing TSX stock in 2025.

Read more »

Happy golf player walks the course
Dividend Stocks

How I’d Turn $5,000 Into a Passive Income Stream This Year

These two high yield TSX stocks offer secured payouts, making them top bets to start building a passive income portfolio…

Read more »

four people hold happy emoji masks
Dividend Stocks

2 Oversold TSX Dividend Stocks to Watch in 2025

These industry leaders have great track records of dividend growth.

Read more »